Abstract

An antibacterial peptide with 16 amino acid residues was found in plasma of the freshwater crayfish, Pacifastacus leniusculus. This peptide, designated astacidin 1, was purified by cation-exchange column chromatography and reverse-phase high performance liquid chromatography. Astacidin 1 has a broad range of antibacterial activity, and it inhibits growth of both Gram-positive and Gram-negative bacteria. The primary sequence of astacidin 1 was FKVQNQHGQVVKIFHH-COOH. The molecular mass was 1945.2 Da, and no carbohydrate-linked amino acid residues could be found by mass spectrometry. A synthetic astacidin 1 resulted in similar activity as the authentic astacidin 1 against Gram-positive bacteria, whereas it had less or no activity against Gram-negative bacteria. Three amino-terminal-truncated synthetic peptides were made; they all showed low activity, suggesting that the amino-terminal part of astacidin 1 contributes to the antibacterial activity. The structure of astacidin 1 based on the CD results showed that it has a beta-sheet structure in citric acid buffer at pH 4, 6, and 8. Cloning of astacidin 1 shows that it is the carboxyl-terminal part of crayfish hemocyanin and that astacidin 1 is produced by a proteolytic cleavage from hemocyanin under acidic conditions. The processing and release of astacidin 1 from hemocyanin is enhanced when crayfish are injected with lipopolysaccharide or glucan.

Highlights

  • Antimicrobial peptides have become recognized as important components of the nonspecific host defense or innate immune system in a variety of organisms ranging from plants and insects to animals, including mollusca, crustaceans, amphibians, birds, fish, mammals, and humans [1,2,3]

  • The eluted fractions were assayed for their antibacterial activity against two bacterial strains, B. megaterium BM11 and E. coli D21

  • The antibacterial molecule was purified to homogeneity and is fully characterized at the level of its primary and secondary structure by a combination of reverse-phase chromatography, cation exchange chromatography, MALDI-TOF-MS, and CD spectrum

Read more

Summary

EXPERIMENTAL PROCEDURES

Animals—Freshwater crayfish, P. leniusculus, were purchased from Berga Kraftodling, Sodermanland, Sweden and were maintained in tanks with aerated water at 10 °C. For purification of antibacterial proteins from plasma, the frozen samples were thawed and trifluoroacetic acid was added to a final concentration of 0.1%. Astacidin 1 Has Antibacterial Activity was centrifuged at 16,000 ϫ g for 20 min, and the supernatant was diluted twice with 0.05% trifluoroacetic acid water and directly subjected to C-18 reverse-phase chromatography (␾ 2.7 ϫ 9 cm, Waters) equilibrated with 0.05% trifluoroacetic acid water. The sample was further purified to homogeneity by reverse-phase HPLC (Amersham Biosciences smart chromatography system) on C-18 column using acetonitrile/water/ 0.05% trifluoroacetic acid gradients of 0 – 60% acetonitrile in 60 min at a flow rate of 100 ␮l/min. Bacteria grown in LB medium (peptone 10 g, yeast extract 5 g, NaCl 5 g, glucose 1 g/distilled water 1 liter) was collected in the exponential phase of growth and resuspended with phosphate-buffered saline, pH 6.0, at a density of 1 ϫ 108 cells/ml. The membranes were prehybridized at 65 °C for 1 h in 5ϫ SSC (750 mM NaCl, 75 mM Na-citrate, pH 7.0), 5ϫ Denhardt’s solution (100ϫ Denhardt’s solution is 2% (w/v) bovine serum albumin,

Amino acid sequence
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.